These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 10893335)
1. Renal resistance to vasopressin in poorly controlled type 1 diabetes mellitus. McKenna K; Morris AD; Ryan M; Newton RW; Frier BM; Baylis PH; Saito T; Ishikawa S; Thompson CJ Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E155-60. PubMed ID: 10893335 [TBL] [Abstract][Full Text] [Related]
2. Dissociation between urine osmolality and urinary excretion of aquaporin-2 in healthy volunteers. Baumgarten R; van de Pol MH; Deen PM; van Os CH; Wetzels JF Nephrol Dial Transplant; 2000 Aug; 15(8):1155-61. PubMed ID: 10910438 [TBL] [Abstract][Full Text] [Related]
4. Attenuation of vasopressin-induced antidiuresis in poorly controlled type 2 diabetes. Agha A; Smith D; Finucane F; Sherlock M; Morris A; Baylis P; Thompson CJ Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1100-6. PubMed ID: 15292031 [TBL] [Abstract][Full Text] [Related]
5. Exaggerated urinary excretion of aquaporin-2 in the pathological state of impaired water excretion dependent upon arginine vasopressin. Saito T; Ishikawa SE; Ando F; Okada N; Nakamura T; Kusaka I; Higashiyama M; Nagasaka S; Saito T J Clin Endocrinol Metab; 1998 Nov; 83(11):4034-40. PubMed ID: 9814488 [TBL] [Abstract][Full Text] [Related]
6. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis. Saito T; Higashiyama M; Nagasaka S; Sasaki S; Saito T; Ishikawa SE Kidney Int; 2001 Oct; 60(4):1266-76. PubMed ID: 11576341 [TBL] [Abstract][Full Text] [Related]
7. Sevoflurane anaesthesia causes a transient decrease in aquaporin-2 and impairment of urine concentration. Morita K; Otsuka F; Ogura T; Takeuchi M; Mizobuchi S; Yamauchi T; Makino H; Hirakawa M Br J Anaesth; 1999 Nov; 83(5):734-9. PubMed ID: 10690135 [TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of aquaporin-2 in the diagnosis of central diabetes insipidus. Saito T; Ishikawa SE; Sasaki S; Nakamura T; Rokkaku K; Kawakami A; Honda K; Marumo F; Saito T J Clin Endocrinol Metab; 1997 Jun; 82(6):1823-7. PubMed ID: 9177390 [TBL] [Abstract][Full Text] [Related]
9. Chronic hypernatremia derived from hypothalamic dysfunction: impaired secretion of arginine vasopressin and enhanced renal water handling. Fukagawa A; Ishikawa SE; Saito T; Kusaka I; Nakamura T; Higashiyama M; Nagasaka S; Kusaka G; Masuzawa T; Saito T Endocr J; 2001 Apr; 48(2):233-9. PubMed ID: 11456273 [TBL] [Abstract][Full Text] [Related]
11. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus. Zhang Y; Peti-Peterdi J; Müller CE; Carlson NG; Baqi Y; Strasburg DL; Heiney KM; Villanueva K; Kohan DE; Kishore BK J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780 [TBL] [Abstract][Full Text] [Related]
12. Decrease in urinary excretion of aquaporin-2 associated with impaired urinary concentrating ability in diabetic nephropathy. Nakamura T; Saito T; Kusaka I; Higashiyama M; Nagasaka S; Ishibashi S; Ishikawa SE Nephron; 2002 Oct; 92(2):445-8. PubMed ID: 12218327 [TBL] [Abstract][Full Text] [Related]
13. The effects of intrinsic vasopressin on urinary aquaporin-2 excretion and urine osmolality during surgery under general anesthesia. Otsuka F; Morita K; Takeuchi M; Yamauchi T; Ogura T; Sekines K; Miura M; Hirakawa M; Makino H Anesth Analg; 1999 Jan; 88(1):181-7. PubMed ID: 9895089 [TBL] [Abstract][Full Text] [Related]
14. COX-2 disruption leads to increased central vasopressin stores and impaired urine concentrating ability in mice. Nørregaard R; Madsen K; Hansen PB; Bie P; Thavalingam S; Frøkiær J; Jensen BL Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1303-13. PubMed ID: 21880835 [TBL] [Abstract][Full Text] [Related]
15. Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment. Zittema D; Casteleijn NF; Bakker SJ; Boesten LS; Duit AA; Franssen CF; Gaillard CA; Gansevoort RT PLoS One; 2017; 12(1):e0169263. PubMed ID: 28081165 [TBL] [Abstract][Full Text] [Related]
16. Partial renal resistance to arginine vasopressin as an adaptation to high altitude living. Ramirez G; Pineda D; Bittle PA; Rabb H; Rosen R; Vesely D; Sasaki S Aviat Space Environ Med; 1998 Jan; 69(1):58-65. PubMed ID: 9451536 [TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of the aquaporin-2 water channel exaggerated in pathological states of impaired water excretion. Saito T; Higashiyama M; Nakamura T; Kusaka I; Nagasaka S; Saito T; Ishikawa S Clin Endocrinol (Oxf); 2001 Aug; 55(2):217-21. PubMed ID: 11531928 [TBL] [Abstract][Full Text] [Related]
18. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration. Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972 [TBL] [Abstract][Full Text] [Related]
19. Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Pedersen RS; Bentzen H; Bech JN; Pedersen EB Am J Physiol Renal Physiol; 2001 May; 280(5):F860-7. PubMed ID: 11292629 [TBL] [Abstract][Full Text] [Related]
20. AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla. Li XC; Shao Y; Zhuo JL Kidney Int; 2009 Jul; 76(2):169-77. PubMed ID: 19387470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]